Novavax SG&A Expense (TTM) Insights | YCharts

Novavax, Inc. (NVAX)

10.22 -0.12 (-1.16%) USD | NASDAQ | Sep 04, 16:00

10.19 -0.03 (-0.29%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NVAX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
June 30, 2026	121.22M
March 31, 2026	138.17M
December 31, 2025	157.48M
September 30, 2025	201.70M
June 30, 2025	240.79M
March 31, 2025	298.48M
December 31, 2024	337.18M
September 30, 2024	414.08M
June 30, 2024	450.79M
March 31, 2024	443.21M
December 31, 2023	468.95M
September 30, 2023	475.37M
June 30, 2023	490.79M
March 31, 2023	505.23M
December 31, 2022	488.69M
September 30, 2022	411.24M
June 30, 2022	366.16M
March 31, 2022	331.16M
December 31, 2021	298.36M
September 30, 2021	275.46M
June 30, 2021	254.54M
March 31, 2021	199.10M
December 31, 2020	145.29M
September 30, 2020	92.16M
June 30, 2020	43.18M

Date	Value
March 31, 2020	35.06M
December 31, 2019	34.42M
September 30, 2019	35.46M
June 30, 2019	35.87M
March 31, 2019	34.49M
December 31, 2018	34.41M
September 30, 2018	33.72M
June 30, 2018	33.53M
March 31, 2018	34.25M
December 31, 2017	34.45M
September 30, 2017	34.25M
June 30, 2017	39.69M
March 31, 2017	44.85M
December 31, 2016	46.53M
September 30, 2016	47.03M
June 30, 2016	42.54M
March 31, 2016	35.53M
December 31, 2015	30.84M
September 30, 2015	27.05M
June 30, 2015	22.74M
March 31, 2015	21.46M
December 31, 2014	19.93M
September 30, 2014	18.95M
June 30, 2014	18.05M
March 31, 2014	16.26M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Moderna, Inc.	965.00M
Merck & Co., Inc.	11.14B
Pfizer Inc.	13.72B
Recursion Pharmaceuticals, Inc.	151.41M
Agenus, Inc.	38.48M